Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the US. It offers multiple products under a portfolio of cannabis consumer packaged goods brands.

Green Thumb Industries holds a weight of 25.71 percent in the MSOS fund. Its share price has dropped by 15.79 percent year-to-date as of the end of April, at which time the operator had a price point of C$9.60.

Curaleaf Holdings is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. Curaleaf bills itself as one of the only US-based state operators that is expanding into the emerging European cannabis market.

Curaleaf holds a weight of 17.38 percent in the MSOS fund. Its share price has dropped by 37.06 percent year-to-date and held a price point of C$3.43.

Trulieve Cannabis is a vertically integrated and fully licensed seed-to-sale medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale and distribution of medical cannabis. Trulieve is based in the state of Florida, and holds a dominant market share in the Sunshine State. However, the firm has expanded its reach into other legal state markets as well.

Trulieve holds a weight of 15.24 percent in the MSOS fund. Its share price has dropped by 26.43 percent year-to-date to a price point of C$7.32 on April 28.

Verano Holdings is a vertically integrated multi-state operator in the US. The firm operates licensed cannabis cultivation, processing and retail facilities, and produces a suite of premium, artisanal cannabis products sold under its portfolio of consumer brands.

Verano holds a weight of 12.06 percent in the MSOS fund. Its share price has dropped by 5.23 percent year-to-date as of the end of April and had a price point of C$3.99.

TerrAscend is a Toronto headquartered cannabis operator with interests across the US, particularly in Pennsylvania, New Jersey, Michigan, California and Maryland.

TerrAscend holds a weight of 8.39 percent in the MSOS fund. Unlike its peers, the share price for this operator has increased by 49.02 percent year-to-date to C$2.28.

Cronos Group cultivates and sells medicinal and recreational cannabis in Canada. Although it primarily operates in Canada, Cronos exports medical cannabis abroad as well as, and has partnerships outside of Canada. The firm also sells hemp-derived CBD products in the US through a partnership with PharmaCann.

Cronos makes up 12.06 percent of the total weight of the HMMJ fund, and its share price has dropped 25.2 percent to C$1.87 so far this year.

Tilray Brands is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and renamed itself after the latter company. The bulk of Tilray's sales are in Canada and in the international medical cannabis export market. The company's US exposure consists of CBD products.

Tilray represents 10.82 percent of the total weight of the HMMJ fund, and its share price has dropped 14.55 percent over a year-to-date period. This grower had a price of C$1.87 at that time.

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, as well as hemp, through a portfolio of brands. Additionally, the firm has interests in the US with an acquisition option for Acreage Holdings (CSE:ACRG.A.U,OTCQX:ACRHF). The firm has the financial backing of alcohol-maker Constellation Brands (NYSE:STZ).

Canopy accounts for 5.94 percent of the total weight of the HMMJ fund, and its share price has dropped 43.72 percent over a year-to-date period. This grower closed the month of April with a price per share of C$1.30.

SNDL, formerly Sundial Growers, is engaged in producing and marketing cannabis for the adult-use market. The company's primary focus is on producing and distributing inhalable products and brands. SNDL is pursuing international assets in addition to its Canadian operations, and has expanded internationally with holdings in Germany and Israel.

SNDL stands at about 4.2 percent of the total weight of the HMMJ fund, and its share price has dropped 28.02 percent over a year-to-date period to C$1.49.

Organigram Holdings is a Canadian licensed producer of cannabis products. The company focuses on producing indoor-grown cannabis for patients and adult recreational consumers, and is developing global business partnerships. Organigram has undergone a restructuring plan in order to focus on pursuing organic revenue growth.

Shares of Organigram represent 2.29 percent of the total weight of the HMMJ fund, and its share price has dropped 35.06 percent over a year-to-date period. This grower closed the month of April with a price per share of C$0.50.